STARTUP PROFILE

Epia Neuro

COUNTRY
USA
FOUNDED
2021
CATEGORY
Brain-Computer Interface
Developing minimally invasive brain-computer interfaces that decode motor intent and pair neural sensing with stimulation to restore function after stroke.
Visit website →
Neurofounders Insights
$   Funding   -
Unknown
MODALITY
ECoG
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Epilepsy
TARGET USER
Clinicians
REGULATORY STAGE
Preclinical
Epia neuro has minimal public information available, making detailed competitive analysis difficult. Based on the domain name and URL, the company appears to operate in the epilepsy diagnostics or monitoring space, placing it adjacent to Ceribell and Epitel, though the specific modality, form factor, and regulatory stage remain undisclosed.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Epia Neuro